[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
I left a message for Glenn Noronha, Ph.D., Executive Vice President, Research and Development Dr. Noronha has served as...
SLNCF - Silence Therapeutics - Not much news generally, but today's is good: "Silence Therapeutics plc, AIM: SLN (‘Si...
NovaBay Expands Sales Force for Avenova Tue January 20, 2015 7:00 AM|Business Wire | About: NBY 35-person sales t...